Figure S3. SF3 Xcelligence data from Differential Effects of Clinically Relevant N- versus C-Terminal Truncating CDKN1A Mutations on Cisplatin Sensitivity in Bladder Cancer

Autor: Philip H. Abbosh, Wafik S. El-Deiry, Erica R. McKenzie, Ali Behbahani, Alexander L. Metz, David J. Weader, Robert N. Uzzo, Moataz Ellithi, Rahmat K. Sikder
Rok vydání: 2023
DOI: 10.1158/1541-7786.22513659.v1
Popis: Figure S3: SW780 and RT4 cells are sensitized to cisplatin after the loss of p21. SW780 sg12A clone is more sensitive to cisplatin than sg109A clone, whereas in RT4, the sg12A and sg109a clones have similar sensitivities to cisplatin.
Databáze: OpenAIRE